Cm Management, LLC Bristol Myers Squibb CO Transaction History

Cm Management, LLC

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2022 May 09, 2022	SELL	$61.48 - $73.72 $922,200 - $1.11 Million	-15,000 Closed	0 $0
Q4 2021 Feb 02, 2022	BUY	$53.63 - $62.52 $804,450 - $937,800	15,000 New	15,000 $935,000
Q3 2021 Nov 08, 2021	SELL	$59.17 - $69.31 $1.18 Million - $1.39 Million	-20,000 Closed	0 $0
Q1 2021 May 12, 2021	BUY	$59.34 - $66.74 $1.19 Million - $1.33 Million	20,000 New	20,000 $1.26 Million

2,428

1.5B

29.7M

32.2M

Ticker BMY
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 2,126,160,000
Market Cap $113B
Description
Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, and markets biopharmaceutical products worldwide. It offers products for hematology, oncology, cardiovascular, immunology, fibrotic, neuroscience, and covid-19 diseases. The company's products include Revlimid, an oral immunomodulatory drug for the treatment of multiple my...

Get notified when there are updates to the investment portfolio of Cm Management, LLC, based on Form 13F filings with the SEC.

Stay updated on Cm Management, LLC with notifications on news.